Kempner Capital Management Inc. Enzo Biochem Inc Transaction History
Kempner Capital Management Inc.
- $192 Million
- Q3 2024
A detailed history of Kempner Capital Management Inc. transactions in Enzo Biochem Inc stock. As of the latest transaction made, Kempner Capital Management Inc. holds 25,475 shares of ENZ stock, worth $18,087. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,475
Previous 25,475
-0.0%
Holding current value
$18,087
Previous $27,000
3.7%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ENZ
# of Institutions
48Shares Held
15.5MCall Options Held
2.3KPut Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$3.67 Million3.43% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.53MShares$1.79 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$1.33 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$1.05 Million3.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$947,4809.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $34.6M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...